Research
- Center for Innovative Therapy (CIT)
- Faculty Labs
- Events
- Lupus Center
- Synovial Biopsy Center
Over the past several decades, researchers in the Division of Rheumatology at UC San Diego have been at the forefront of innovative, cutting-edge basic research in immunology. Clinically, members of the division have conducted a large number of trials of new agents in diseases such as rheumatoid arthritis, osteoarthritis, scleroderma, and systemic lupus erythematosus.
At the end of 1999, the UC San Diego Center for Innovative Therapy (CIT) was established within the division to better coordinate these activities. The goal of the CIT is to facilitate the translation of novel therapeutics for immunologic and inflammatory diseases from the bench to the bedside, with an emphasis on biologicals and investigator-initiated approaches. To accomplish this, the center will initiate and conduct studies assessing novel immunomodulatory therapies. Moreover, laboratory investigations to delineate the pathophysiological basis of rheumatic and other immunologic diseases will be performed in conjunction with the clinical studies.
Our team comprises renowned clinicians, researchers, and support staff, all united by a common goal: to develop and implement cutting-edge therapies that transform patient care.